CytoMed Therapeutics Limited Increase Decrease Through Change In Equity Of Subsidiaries
CytoMed Therapeutics Limited (GDTC) reported Increase Decrease Through Change In Equity Of Subsidiaries of SGD 700.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries · last filed 2026-03-31
| Period end | Increase Decrease Through Change In Equity Of Subsidiaries 12 month |
|---|---|
| 2025-12-31 | 700.00K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 157.85K SGD 20-F · filed 2026-03-31 |